ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients

National Cancer Center, Japan · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
pembrolizumab
angiosarcoma of skin, angiosarcoma metastatic, pembrolizumab, lenvatinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 981850
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.